Target intelligence / Profile preview

Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex (STING-TBK1 complex)

Target
STING-TBK1 complex
Molecular classification
Protein-protein complex, Signalosome, Kinase complex
01

Overview

The Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex is a critical signaling assembly in the cGAS-STING pathway, essential for the induction of innate immune responses to cytosolic DNA. Upon activation by cyclic dinucleotides like cGAMP, STING translocates from the endoplasmic reticulum to the Golgi, where its C-terminal tail recruits TBK1 (Liu et al., 2015, Science; Tanaka & Chen, 2012, Science Signaling). This interaction facilitates the phosphorylation of STING and the transcription factor IRF3 by TBK1, ultimately triggering the production of Type I interferons and pro-inflammatory cytokines (Motwani et al., 2019, Nature Reviews Genetics). In oncology, this complex is a major therapeutic target, with STING agonists being developed to promote its formation and stimulate anti-tumor immunity (Decout et al., 2021, Nature Reviews Immunology). Conversely, overactivation of the STING-TBK1 complex is implicated in autoinflammatory diseases such as STING-associated vasculopathy with onset in infancy (SAVI) and systemic lupus erythematosus, leading to research into inhibitors that disrupt this specific protein-protein interface (Barber, 2015, Nature Reviews Immunology). Targeting the complex directly or its individual components allows for the modulation of the immune system in both cancer and inflammatory contexts.

Other names
TMEM173-TBK1 complexSTING-TBK1 signalosomeSTING-TBK1 interaction
02

Mechanism of action

Agonism of STING to induce complex formation or inhibition of TBK1 to prevent complex-mediated signaling.

03

Biological functions

Innate immune responseSignal transductionType I interferon productionAntiviral responseDNA sensing pathway
04

Disease associations

CancerAutoimmune diseaseInflammationInfection
05

Safety considerations

Cytokine release syndromeAutoimmune reactionsSystemic inflammatory responseImpaired host defense against viruses
06

Interacting drugs

ADU-S100

5 more in the full profile.

07

Biomarkers

Phosphorylated IRF3 (p-IRF3)Interferon-beta (IFN-β)CXCL10 (IP-10)Phosphorylated STING (p-STING)Phosphorylated TBK1 (p-TBK1)

Beyond the preview

Go deeper on Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex (STING-TBK1 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex (STING-TBK1 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call